+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rectal Cancer"

Polyp Biopsy Market Report 2025 - Product Thumbnail Image

Polyp Biopsy Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Tumor Microenvironment Global Market Report 2025 - Product Thumbnail Image

Tumor Microenvironment Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
From
Interventional Oncology Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Interventional Oncology Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Medical Oncology Compendium - Product Thumbnail Image

Medical Oncology Compendium

  • Book
  • March 2025
  • 12 Results (Page 1 of 1)
Loading Indicator

Rectal cancer is a type of cancer that affects the lower portion of the large intestine, or colon. It is one of the most common forms of colorectal cancer, and is often treated with a combination of surgery, chemotherapy, and radiation therapy. Treatment options vary depending on the stage of the cancer, and may include chemotherapy, radiation therapy, and/or surgery. In some cases, a combination of treatments may be used. The oncology market for rectal cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new drugs and treatments to improve outcomes for patients, while medical device companies are developing new technologies to improve the accuracy and effectiveness of diagnosis and treatment. Companies in the rectal cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more